Australia markets closed

Janux Therapeutics, Inc. (JANX)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
41.47-1.75 (-4.05%)
At close: 04:00PM EDT
40.68 -0.79 (-1.90%)
After hours: 05:36PM EDT
Currency in USD
Earnings estimateCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
No. of analysts8899
Avg. Estimate-0.31-0.32-1.31-1.67
Low estimate-0.4-0.41-1.56-2.73
High estimate-0.19-0.17-0.82-0.91
Year ago EPS-0.42-0.25-1.32-1.31
Revenue estimateCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
No. of analysts9999
Avg. Estimate770k910k3.72M2.73M
Low estimateN/AN/A1.25MN/A
High estimate1.6M2.4M8.1M8.3M
Year ago sales1.06MN/A8.08M3.72M
Sales growth (year/est)-27.20%N/A-54.00%-26.60%
Earnings history29/06/202329/09/202330/12/202330/03/2024
Est. EPS-0.52-0.47-0.41-0.33
Actual EPS-0.42-0.25-0.25-0.3
Difference0.10.220.160.03
Surprise %19.20%46.80%39.00%9.10%
EPS trendCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
Current estimate-0.31-0.32-1.31-1.67
7 days ago-0.31-0.32-1.31-1.67
30 days ago-0.32-0.33-1.32-1.7
60 days ago-0.32-0.34-1.35-1.64
90 days ago-0.32-0.35-1.36-1.7
EPS revisionsCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
Up last 7 daysN/AN/AN/AN/A
Up last 30 daysN/AN/AN/AN/A
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimatesJANXIndustrySector(s)S&P 500
Current qtr.26.20%N/AN/AN/A
Next qtr.-28.00%N/AN/AN/A
Current year0.80%N/AN/AN/A
Next year-27.50%N/AN/AN/A
Next 5 years (per annum)145.30%N/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A